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Abstract
Pulsatile blood flow through the cavities of the heart and great vessels is time-varying and multidirectional. Access
to all regions, phases and directions of cardiovascular flows has formerly been limited. Four-dimensional (4D) flow
cardiovascular magnetic resonance (CMR) has enabled more comprehensive access to such flows, with typical
spatial resolution of 1.5×1.5×1.5 – 3×3×3 mm3, typical temporal resolution of 30–40 ms, and acquisition times in
the order of 5 to 25 min. This consensus paper is the work of physicists, physicians and biomedical engineers,
active in the development and implementation of 4D Flow CMR, who have repeatedly met to share experience
and ideas. The paper aims to assist understanding of acquisition and analysis methods, and their potential clinical
applications with a focus on the heart and greater vessels. We describe that 4D Flow CMR can be clinically
advantageous because placement of a single acquisition volume is straightforward and enables flow through any
plane across it to be calculated retrospectively and with good accuracy. We also specify research and development
goals that have yet to be satisfactorily achieved. Derived flow parameters, generally needing further development
or validation for clinical use, include measurements of wall shear stress, pressure difference, turbulent kinetic energy,
and intracardiac flow components. The dependence of measurement accuracy on acquisition parameters is
considered, as are the uses of different visualization strategies for appropriate representation of time-varying
multidirectional flow fields. Finally, we offer suggestions for more consistent, user-friendly implementation of 4D
Flow CMR acquisition and data handling with a view to multicenter studies and more widespread adoption of the
approach in routine clinical investigations.
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Introduction
Pulsatile blood flow through the cavities of the heart
and great vessels is multidirectional and multidimen-
sional. However, access to all the directions, regions
and phases of such flows has been limited with cardio-
vascular magnetic resonance (CMR) as well as other
imaging modalities. Four-dimensional (4D) flow CMR
has been developed to attain more comprehensive ac-
cess to blood flow through the heart and large vessels
[1–4]. This unique technique enables a wide variety of
options for visualization and quantification of flow,
ranging from basic aspects such as flow volume and
peak velocity to more advanced features such as the
estimation of hemodynamic effects at the vessel wall
and myocardium, as well as visualization of flow path-
ways in the heart and great vessels.
“4D Flow CMR” refers to phase-contrast CMR with
flow-encoding in all three spatial directions that is resolved
relative to all three dimensions of space and to the dimen-
sion of time along the cardiac cycle (3D + time = 4D). For
concise description and unification of nomenclature we
recommend the use of the term “4D Flow CMR” or “4D
Flow MRI” as will be used throughout the document. For
methodological clarification, we recommend that a full-
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length description such as “three-dimensional (3D) cine
(time-resolved) phase-contrast CMR with three-directional
velocity-encoding” is included in the methods section of
reports that employ this technique.
In 2012, leading teams in 4D Flow CMR started meeting
on a regular basis to discuss the state of the technique and
directions for future work. This group consists of medical
physicists, physicians, and biomedical engineers who have
been active in cardiovascular 4D Flow CMR research. As
the field has grown, the list of invitees was extended by per-
sonal acquaintance and availability to join regular meetings.
Soon, the need to find a uniform basis for terminology,
potential clinical applications, and various technical aspects
regarding data acquisition, data processing, visualization,
and quantification became apparent. Therefore, we started
a consensus initiative during the 2nd biannual 4D Flow
Workshop held in Oxford, UK, in September 2013 to
summarize our discussions.
This consensus statement aims to assist the under-
standing of the acquisition, analysis, and possible clinical
applications of 4D Flow CMR in the heart and great
vessels (aorta, pulmonary arteries), including all the
steps involved in a 4D Flow CMR study. We will also
discuss research and development goals that have yet to
be achieved, in order to address current limitations and
ensure data reliability and validity.
The consensus statement is based on published data
and the shared experience of the 4D Flow CMR consen-
sus group. The authors understand the manuscript as a
state-of-the-art summary on the acquisition or analysis
of 4D Flow CMR that creates a basis for future multi-
vendor and multicenter research, can serve as a refer-
ence to established research, and provide guidance to
researchers and clinicians new to the field.
Clinical and scientific significance
Flow assessment has long been used in the evaluation
of cardiovascular disease. In recent decades, largely
due to the advent of multidimensional flow imaging
and computational fluid dynamics (CFD), the import-
ance of improving our understanding of physiological
and pathophysiological blood flow conditions is in-
creasingly acknowledged [5, 6].
The most common clinical tool for cardiovascular flow
assessment is Doppler echocardiography, which can meas-
ure the blood flow velocity component in the direction of
the ultrasound beam or provide a 2D visualization of one-
directional blood flow velocities using the color Doppler
mode. Doppler echocardiography is often used to assess
peak and mean velocities in the aorta and pulmonary
artery for calculation of peak and mean pressure drops,
known as gradients, via the simplified Bernoulli equation
[7, 8]. This approach, however, is limited by the con-
straints associated with echo-Doppler imaging, which
include variable velocity assessment (due to beam align-
ment), limited acoustic window, and operator expertise
[9–11]. Further, the calculation of mean velocities and net
flow is often based on assumptions regarding the under-
lying flow profile and vessel cross-sectional area which
may results in inaccurate flow quantification in the pres-
ence of complex flow and/or vessel geometry.
The most common CMR flow imaging technique is 2D
cine phase contrast (PC) CMR with velocity-encoding in a
single direction (2D cine PC-CMR) [12–19]. The single
velocity-encoding direction is typically selected perpen-
dicular to the 2D plane, which enables calculation of the
volume of flow passing through the plane. 2D cine PC-
CMR is arguably the gold-standard for flow volume
quantification. The formerly widely used, but invasive
thermodilution technique for flow quantification, is
subject to inaccuracies due to underlying assumptions.
Unlike Doppler echocardiography or 2D cine PC-CMR,
4D Flow CMR acquisition includes measurements re-
presenting all directions and spatial regions of flow
within the boundaries of the volume imaged. Although
methodologically different, computational fluid dynam-
ics (CFD) is comparable in terms of multidirectional,
volumetric representation [20–25]. Flow fields can po-
tentially be calculated by CFD to high spatial and tem-
poral resolution [26–28]. However, CFD requires accurate
definition of geometrical and physiological boundary
conditions and the ability of the computed flow fields to
represent reality depends on the precision of the boundary
conditions and the validity of underlying assumptions. For
these reasons, CFD is currently not used in clinical
decision-making. The relatively direct, voxel by voxel
measurements of velocity provided by 4D Flow CMR
can be complementary to the higher resolution velocity
fields computed by CFD.
Clinical utility
CMR-based flow volume quantification is routinely
used at many institutions to estimate shunt flows,
regurgitant flows, collateral flows, etc. [29, 30]. These
diagnostic tests are primarily based on 2D cine PC-
CMR. A large number of studies across different insti-
tutions and MR-systems have demonstrated that 4D
Flow CMR permits flow volume quantification that is
comparable to 2D cine PC-CMR [31–39] and has good
scan-rescan repeatability [32, 40, 41]. A recent study
that assessed Qp/Qs ratios in intracardiac shunts
reported that flow volumes are underestimated com-
pared to 2D cine PC-CMR but that the Qp/Qs ratios
were not different [42]. 2D cine PC-CMR has been
hampered by artifacts such as background phase
offsets which can lead to errors inflow volume mea-
surements. These issues are shared by 4D Flow CMR and
proper measures to compensate for them are necessary.
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However, flow volume quantification with 4D Flow CMR
has several advantages when compared to 2D cine PC-
CMR. 4D Flow CMR permits investigation of the internal
consistency of the data by employing the ‘conservation of
mass’ principle (e.g. Qp/Qs within the same dataset). This
important feature lends itself well to standardization of
data quality assurance and will be discussed later. Investi-
gators have used this feature and demonstrated that flow
volume measurements with 4D Flow CMR have good
internal consistency [32, 38, 41–49].
Another advantage of 4D Flow CMR is the retrospect-
ive placement of analysis planes at any location within
the acquisition volume. While standard 2D cine PC
techniques can easily be applied during a single breath
hold, 4D Flow CMR on the other hand, offers the ability
to retrospectively calculate blood flow through any
planes of interest across the 3D volume. Despite longer
scan times, 4D Flow CMR allows easy scan prescription
(positioning of a single 3D volume) compared to the
need to predetermine and accurately locate all relevant
planes of 2D acquisitions. This may be especially advan-
tageous in cases where multiple 2D cine PC-CMR scans
would be needed [36]. In these situations, 4D Flow CMR
may even be faster than prescribing and scanning a
series of 2D cine breath-held PC CMR acquisitions,
enabling a reduced period of anesthesia for younger chil-
dren or of scan time in decompensated patients. Further,
the option of valve tracking may improve assessment of
flow through heart valves [43]. Compared to 2D cine
PC-CMR, 4D Flow CMR measures velocity in all spatial
directions and has superior spatial coverage and may
therefore also be better at capturing the peak velocity of
a stenotic jet [37]. However, one recent study suggested
that the peak flow rate was lower for 4D compared to
2D flow [35]. These findings may in part be explained by
relatively low temporal resolution (50–55 ms). Similarly,
another recent study with 46 ms temporal resolution
obtained smaller net flow volumes with 4D compared to
2D flow CMR [42]. Larger, preferably multicenter, stud-
ies with optimized protocols would be helpful to estab-
lish the comparability between 2D and 4D Flow CMR,
as well as the spatial and temporal resolution needed
for different applications.
In addition to the flexible retrospective quantifica-
tion of conventional flow parameters, 4D Flow CMR
allows for the visualization of multidirectional flow
features and alterations of these associated with car-
diovascular disease [50–53]. Previously reported re-
sults include the application of 4D Flow CMR for the
analysis of blood flow in the ventricles [54–63] and
atria [64–67] of the heart, heart valves [3, 43, 68, 69],
aorta [41, 69–82], main pulmonary vessels [83–86],
carotid arteries [87–90], large intracranial arteries and
veins [91–98], arterial and portal venous systems of
the liver [46, 85, 99–101], peripheral arteries [102] and
renal arteries [103, 104]. The intuitive flow visualizations
that 4D Flow CMR offers have already found utility in
several clinical studies. For example, time-resolved visuali-
zations of blood flow have been used clinically to identify
flow directionality and areas of flow acceleration in
visceral abdominal blood flow [105–107]. In addition, a
number of studies have shown that visualization of
aortic blood flow can be helpful to quickly identify
regions with high velocity flow close to the vessel wall
that may indicate altered fluid mechanical effects on
the vessel wall [69, 74, 108–110]. Finally, there are
promising applications in complex congenital heart
disease [39, 85, 111, 112]. While these examples are
promising and illustrate the potential of 4D Flow analysis
to better understand complex hemodynamic patterns, the
clinical utility needs further evaluation in larger prospect-
ive and multi-center trials. For a more detailed overview
of recent 4D Flow CMR developments and its use for 3D
flow visualization and quantification throughout the hu-
man circulatory systems the reader is referred to a number
of recently published review articles [113–118].
Research utility
4D Flow CMR has made it possible to investigate in-vivo
cardiovascular flow fields more comprehensively than
was previously possible. Multidisciplinary research teams
are using the technique to 1) address gaps in the under-
standing of cardiovascular physiology and pathophysi-
ology, 2) better understand the impact of hemodynamics
on the heart and vasculature, 3) delineate further to
what degree alterations of flow predispose to or result
from cardiovascular disease processes such as remodel-
ing, and 4) assess the degree to which physiological flow
and pressure profiles have been restored following inter-
ventional or surgical procedures. Thus, by affording
visualization and quantification of flow parameters ran-
ging from conventional parameters such as flow volume
and regurgitant fraction to more advanced parameters
such as flow energetics and shear stress, there are several
applications where 4D Flow CMR has significant poten-
tial for advancing our knowledge and assessment of the
cardiovascular system. For example, 4D Flow CMR has
been used to demonstrate separation of blood that transits
heart chambers according to compartmental origin and
fate, retrograde flow embolization pathways from the
descending aorta to the brain, and associations of valve out-
flow jet patterns with aortopathy [56, 74, 82, 109, 119–124].
In addition, the technique can be used to derive new
physiologic and pathophysiologic hemodynamic param-
eters such as such as wall shear stress [125–127], pres-
sure difference [103, 128–131], pulse wave velocity
[132, 133], turbulent kinetic energy [134–137], and
others [57, 58, 122, 138–141] for more differentiated
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characterization of cardiovascular pathophysiology be-
yond simple measures of flow. The majority of these
in-vivo hemodynamic measures cannot be assessed
non-invasively with any other imaging technique. In all
areas, further studies are required to assess the clinical
impact of these measurements.
Consensus recommendations
This section provides recommendations for the use of
4D Flow CMR for 3D flow visualization and quantifica-
tion of flow volume, retrograde flow and peak velocity in
the heart and large vessels (aorta, pulmonary arteries).
We focus on basic flow visualization and standard CMR
parameters which can most easily been incorporated
into routine clinical application. More advanced parame-
ters such as pressure difference mapping, wall shear
stress and turbulent kinetic energy are not addressed in
this section but will be discussed in the future work
section below. Table 1 lists analysis parameters and visu-
alizations that are recommended for different clinical
indications. The recommendations for quantification are
based on the literature described in the “Clinical utility”
section above. We emphasize that the amount of
supporting literature is smaller for flow visualization
compared to quantification and thus the recommenda-
tions are primarily based on consensus discussions.
Several steps are required to assess blood flow with 4D
Flow CMR including proper patient preparation, choice
of acquisition parameters, and data conditioning through
pre-processing, and data analysis. We suggest a struc-
tured workflow for data acquisition and processing as
shown in Fig. 1.
Patient preparation
4D Flow CMR requires a reliable ECG trace with detect-
able R-wave to ensure consistency between RR-intervals.
Standard ECG positioning applies. For aortic flow assess-
ment it is important that the surface coils are positioned
high enough to also fully encompass the aortic arch,
which can be quite high in some aortic pathologies. 4D
Flow CMR scans can be relatively long and it is useful to
inform the patient about this prior to starting the scan in
order to minimize discomfort.
4D flow CMR data acquisition
PC-MR signal and use of contrast agents
4D Flow CMR employs spoiled gradient echo se-
quences with short TR for rapid imaging. As such, the
Table 1 Recommended 4D Flow CMR analysis for different clinical indications - all aspects below can be derived from a single
acquisition. For a comprehensive overview of 4D Flow CMR quantification and visualization methodology including additional
references please see recently published review articles [113–118]
Clinical indication Quantification Visualizationa
Heart valve disease (stenosis, regurgitation) Flow volume • Identification of regurgitant and stenotic jets using
streamlines and pathlines
• Regurgitant flow volumes & fraction • Peak velocity location by systolic streamlines or maximum
intensity projections of speed images
Peak velocity • Outflow patterns using streamlines
• Estimated pressure gradients with
modified Bernoulli equation
• Time course of flow curve
Shunts and collateral vessels (Ventricular-septal
defect, atrial-septal defect, fistulae)
Flow volume • Identification of shunt flow and flow directionality using
pathlines
• Shunt flow volume
• Qp/Qs
Complex congenital heart disease (e.g. single
ventricle physiology, Fontan circulation,
Fallot’s tetralogy),
Flow volume • Flow directionality using pathlines
• Regurgitant flow volumes & fraction • Shunt flow using pathlines
• Flow distribution (e.g. left vs right
pulmonary artery, relative SVC/IVC flow)
• Flow connectivity and distribution using pathlines
• Collateral flow volume
Peak velocity
Aortic disease (aneurysm, coarctation,
dissection)
Flow volume • Peak velocity location by systolic streamlines or maximum
intensity projections of speed images
• Regurgitant flow volumes & fraction • Identification of flow in false lumen and potential entry/
exit sites
• Relative flows in true & false lumen • Identification of highly disrupted flow patterns (likely to
reduce forward flow) in tortuous aortic conditions
Peak velocity
aThe amount of supporting literature is smaller for visualization compared to quantification
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signal magnitude from the blood is weighted inversely
with the T1 relaxation time. This allows for the gener-
ation of PC angiograms without the need for an exter-
nal contrast agent [107, 142]. Although 4D Flow CMR
does not require any contrast agents, it is often used as
part of a comprehensive CMR study that does requires
the use of T1 shortening gadolinium-based contrast
agents, for example for perfusion MRI or late gadolin-
ium enhancement imaging. In such cases, acquiring the
4D Flow CMR data after the study that requires con-
trast administration takes advantage of the enhanced
signal-to-noise ratio (SNR) and thus velocity to noise
ratio (VNR) as well as contrast between blood and
surrounding tissue [107, 143, 144]. However, contrast
agents that wash out during the 4D Flow scan can re-
sult in time-varying blood T1 times and the effects of
this variability on PC-CMR velocity data is not fully
known. As a result, the effect of contrast agents depend
on the type (extravascular vs. intravascular) and SNR,
VNR can vary depending on the timing of the contrast
agent administration.
Scan parameters
Table 2 provides an overview of the most important scan
and reconstruction parameters and lists recommended
values for each of them. The recommendations are primar-
ily based on the experience of the authors of this consen-
sus document and the literature that has investigated 4D
Flow-based flow volume quantification [31–38, 40–48].
We propose this list of parameter settings as a baseline 4D
Flow CMR protocol against which alterative protocols can
be compared. Specialized applications such as measure-
ments in a paediatric population or analysis of advanced
flow parameters may require optimized parameter choices.
Table 2 also indicates the potential advantages of ‘ideal’
parameters, the factors that may prevent their achievement
and a value of the parameter that has been shown to be
practicable and sufficient for most flow quantification in
4D Flow CMR covering the heart and/or large vessels
(aorta, pulmonary artery) in healthy adults. The main tech-
nical goal of a 4D Flow CMR acquisition is accuracy. This
is largely determined by sufficient spatial and temporal
resolution, and adequate SNR (hence VNR). The accuracy
Fig. 1 Recommended workflow for clinical application of 4D Flow CMR with the main components of 1) patient preparation, 2) data acquisition
in the magnet, 3) data reconstruction, 4) pre-processing of the reconstructed data, and 5) data analysis
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is also affected by artefacts. The practical achievability of
the optimum parameter values is mostly hampered by total
scan time, the methods availability and validity as well as
system imperfections.
4D Flow CMR requires the user to define an upper vel-
ocity limit, termed the velocity encoding range (venc),
similar to 2D cine PC-CMR techniques. Venc is defined
as the (positive or negative) velocity that gives a phase
Table 2 4D Flow CMR scan parameters
Ideally Reason Limiting factor Consensus value
Acquisition Parameters
Field of view Max SNR, coverage Scan time, system
imperfections
Cover region of interest
Spatial resolutiona Maximum, at least
5–6 voxels across vessel
diameter of interestb,
isotropic resolution.
Accuracy Scan time, SNR <2.5×2.5×2.5 mm3 for aorta or pulmonary
artery
<3.0×3.0×3.0 mm3 for whole heart and
greater vessels
Velocity encoding
timing (beat- vs.
TR-interleaved)
TR-interleaved Avoid inter-cycle
variability
Temporal resolution TR-interleaved
k-space segmentation
factor
1 Accuracy (temporal
resolution)
Scan time 2
Temporal resolutionc Max Accuracy Scan time <40 ms
ECG synchronizationd Retrospective Cover entire ECG cycle,
avoid sequence
interruption
Reconstruction complexity If available: retrospective
Else: Prospectivee
Respiratory motion
compensationf
100 % acceptance,
motion correction
Scan time, reduction
of breathing artifacts
Reconstruction complexity,
robustness, breathing
artefacts (ghosting and
blurring)
If available: Leading or trailing MR
navigator on liver/diaphragm interface,
6 mm window size, typically resulting in
50 % acceptance rate.
Otherwise: Bellows with 50 % acceptance
rate.
Partial k-space coverage
in phase- and slice-
encoding directions
Full k-space coverage SNR, resolution Scan time If available: Elliptical k-space
Otherwise: Half scan 75 % × 75 % (y × z)
Flip Angleg Ernst angle:
α = acos(e-TR/T1)
SNR Contrast vs. SNR Ernst angle
Parallel Imaging No parallel imaging SNR Scan time R = 2-3 (depends on #channels in coil array)
k-t undersamplingh No k-t under sampling SNR Scan time If available: R = 4-5
Venc Maximum expected
velocity, multiple vencs
VNR, avoid aliasing Scan time Single venc, 10 % higher than maximum
expected velocity
Postprocessing Parameters
Maxwell correction Yes Accuracy Yes
Eddy current correction Yes Accuracy Different methods and
their validity and robustness
Yes
Phase unwrapping Yes Accuracy Different methods and their
validity and robustness
Yes
Gradient non-linearity
correction
Yes Accuracy Availability If available
aAlways indicate the effectively acquired resolution in combination with the interpolated resolution
bStudies have demonstrated that 5–6 voxels across the vessel diameter is sufficient for flow volume quantification [165]
cAlways indicate the effectively acquired resolution. If a temporal interpolation is performed, also indicate the interpolated temporal resolution along with the
interpolation method used
dSo called self-gating techniques have been evaluated and may become an alternative to the ECG [32]
eFor prospective gating, analyses that involve integration over the whole cardiac cycle needs to be accompanied with a description of how the incomplete
temporal coverage was handled
fDifferent types of respiratory navigators exist; variants include approaches that allow less motion in the central parts of k-space. Always describe the method that
has been used and indicate the mean navigator efficiency in percent as well as the navigator acceptance window in mm. For fix window sizes and no k-space
reordering, 6 mm navigator window is recommended, and this typically results in 50 % navigator efficiency
gThe SNR is strongly dependent on the in-flow effect, therefore the flip angle can be and is often chosen higher than the Ernst angle. When using contrast agents,
the Ernst angle further increases (due to lower T1)
hk-t undersampling factor 4–5 in combination with conventional parallel imaging factor 2–3 is not recommended
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shift of π radians. Since phase is a cyclic entity, phase
shifts greater than π radians result in velocity aliasing,
which are visible as phase wraps in flow images. Higher
venc results in lower VNR. We recommend choosing a
venc slightly greater than the maximum velocity expected
in the territory of interest. In stenotic and regurgitant
flows, a multi-venc approach can be useful.
The total scan time available for adding 4D Flow CMR
to a routine clinical CMR exam is often the most im-
portant limiting factor. If the total 4D Flow scan time is
limited, e.g. not more than 5–8 min, the following trade-
offs may be useful:
1. Acquire free-breathing 4D Flow CMR without re-
spiratory gating to increase scan efficiency (studies
have demonstrated reasonably accurate flow volume
quantification without compensation for respiratory
motion) [32, 34].
2. Reduce temporal resolution by increasing the k-
space segmentation factor to 3. This decreases the
temporal resolution from approximately 40 ms to
60 ms and may result in reduced accuracy of peak
velocity and flow volume quantification.
3. Reduce spatial resolution and SNR by acquiring
65 % × 65 % of ky and kz phase encoding lines
Employing these parameter adjustments can result in a
substantial reduction of scan time. However, these changes
will result in decreased spatiotemporal resolution and SNR
and increased artifacts, which negatively impact flow
quantification and visualization accuracy. Deviations from
a validated standard protocol should be followed up by
additional quality control.
In order to achieve comparability between different
studies and to facilitate reproducibility of previously
published work, a crucial requirement is the inclusion of
all major scan and post-processing parameters in pub-
lished reports. We recommend listing all scan parameters
included in Table 2, and we encourage authors to specify
the employed flow-encoding scheme, such as symmetric,
asymmetric, or Hadamard 4-point encoding, 5-point-
encoding, multipoint encoding etc. [137, 145–147]. The
total scan time should be listed as the total scan time
including respiratory gating efficiency or as the total scan
time excluding navigator efficiency in combination with
the respiratory gating efficiency.
Data pre-processing
4D Flow CMR data processing usually involves the use
of automated or semi-automated corrections of known
artefacts and often requires calculation of a geometric
representation of the underlying 3D cardiac or vascular
geometry through segmentation. Several sources of error
can compromise 4D Flow CMR analysis and need to be
addressed prior to flow quantification and visualization.
Similar to 2D cine PC-CMR, the major sources of errors
include eddy current effects [148], concomitant gradient
field effects (Maxell terms) [149], gradient field non-
linearity [150, 151], and phase wraps resulting in velocity
aliasing [152, 153]. Correction strategies have been pre-
sented in the literature and should be applied and evaluated
to ensure accurate flow quantification and visualization
[148–151, 154]. Investigators have also explored various
types of image enhancement methods (noise filtering, di-
vergence free corrections, etc.) to improve data quality. The
use of such methods should be clearly reported in ma-
nuscripts, as they can also affect data quality negatively.
Details and recommendations for the most common types
of data processing are provided below. We emphasize that
optimal approaches for data processing, especially correc-
tions for background phase offsets, may vary between MR
systems, sequences, protocols and applications.
Background phase offsets, concomitant gradient fields
Concomitant gradient fields, also referred to as Maxwell
fields, lead to spatially varying background phase offsets
in any type of PC-CMR acquisition. Correction factors
for the concomitant gradient field correction can be dir-
ectly derived from the gradient waveforms used for the
data acquisition [149]. This correction scheme is imple-
mented on MR systems as part of the standard PC-CMR
image reconstruction engine.
Background phase offsets, Eddy currents
The switching of time-varying magnetic field gradients
result in changes in magnetic flux which in turn induce
eddy currents in the conducting parts of the scanner
system. These eddy currents alter the strengths and
durations of the desired gradients and thus result in
spatially and temporally varying phase offsets in any
type of PC-CMR [155, 156]. Modern MR scanners have
pre-emphasis systems that adjust the gradient wave-
forms by incorporating predictions of eddy currents
effects. However, not all eddy current effects can be
compensated for and there currently is no definite so-
lution to remove all eddy current induced background
phase offsets. We recommend the approach of fitting
polynomials through the phase of tissue known to be
static [148]. It should be noted that the order of the poly-
nomial and the approach to detect static tissue may be
vendor, sequence, and application specific. Assessment of
heart-phase dependent differences is recommended.
Phase wraps, velocity aliasing
Blood flow velocities that exceed the velocity sensitivity
(venc) value result in velocity aliasing, or phase wraps. We
recommend that the venc is set higher than the maximum
expected velocity. However, such a venc setting can cause
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insufficient VNR in interesting flow regions with low
velocity. Also, it is not always possible to predict the max-
imum velocity. We therefore recommend the use of a
phase-unwrapping algorithm. The phase-unwrapping al-
gorithm should be robust and not risk introducing add-
itional errors. Identification of abrupt phase shifts in the
temporal domain is a commonly used approach [153]. It
should be noted that the visual perception and optimal
phase-unwrapping strategies are different for different
flow-encoding schemes.
Phase-Contrast Magnetic Resonance Angiography (PC-MRA)
4D Flow CMR data can be used to derive time-
averaged 3D phase-contrast MR angiography (PC-MRA)
based on the combination of velocity and magnitude data
[142, 143, 157, 158]. The 3D PC-MRA can be used to
guide anatomic orientation for flow visualization and re-
gional flow quantification.
Data analysis
Flow visualization
We generally recommend users of 4D Flow CMR to en-
gage in visualizations and learn to interact with the data.
Multiple options for the visualization of volumetric,
time-resolved velocity vector fields on a 2D screen exist
and none is entirely representative of the rich underlying
data. It is a matter of choosing the proper visualization
approach or combination of approaches that best ad-
dress a particular question.
Visualization techniques commonly used with 4D Flow
CMR include vector maps, streamlines and pathlines as
well as maximum intensity projections, isosurfaces and
volume renderings (see Figs. 2 and 3) [50, 51, 54, 159]. The
choice of one technique over another, and the choice of a
color map, depends on the application in question, the dis-
play medium and the time available for processing, among
other factors. Visualization of 4D Flow data can be time-
consuming and often benefits from informed user inter-
action. Interactive user-guided visualizations are valuable
for generation of flow-based hypotheses. Efforts toward
more standardized automated flow visualization ap-
proaches could be helpful in certain applications and
would minimize operator-dependent variation, although
users should understand the principles, strengths and
limitations of different techniques. Further descriptions of
the various approaches and their applications can be
found in recent review articles [113–118, 159, 160].
Relatively thorough interrogation of a flow field can be
achieved by interactively browsing through the slices of a
4D dataset using vector map displays and/or color coding
according to speed (magnitude of the velocity vector)
(Fig. 2a) or by creating a maximum ‘intensity’ projection
(MIP) for speed (Fig. 2b). Instantaneous streamlines can
be used to represent the directions of flow throughout
a cavity or vessel at a given cardiac phase. Comparable
instantaneous visualizations are achieved by 3D velocity
vector maps, which display the magnitude and direc-
tion of blood velocity of each voxel. Instantaneous
streamlines are traces through a 3D velocity field, paral-
lel to the velocity vectors at all spatial points along their
length. They represent a specific temporal phase (see
Fig. 2c and Fig. 3c-e). An instantaneous streamline does
not, in a pulsatile flow field, correspond with the path
traveled by any given blood cell [161]. In contrast, path-
lines (Fig. 2d and Fig. 3a-b), follow the paths of virtual
massless particles. Streamlines and pathlines of a pulsa-
tile flow field differ from each other, and each should
be interpreted accordingly. To explore the path of
blood through space and time, pathlines are likely to be
more telling, whereas instantaneous streamlines would
be more suitable for depictions of instantaneous flow
features. Inclusion of the adjective “instantaneous” (in-
stantaneous streamlines) helps to avoid confusion.
Many analysis parameters, such as flow speed, vorticity
and turbulent kinetic energy, are scalar fields that can be vi-
sualized using MIP images or isosurface and volume ren-
dering techniques. Isosurfaces and volume renders can be
combined with vector graphs, streamlines or pathlines to
create visualizations of multiple parameters. 4D Flow CMR
visualizations may also be fused with other types of MR
images, such as contrast-enhanced MR angiography and
balanced steady-state free-precession (bSSFP) cine images
to display anatomy. Such combinations can provide add-
itional integration of cardiovascular morphology and func-
tion (see example in Fig. 3).
Flow quantification
Flow volume and retrograde flow quantification in 4D
Flow CMR is similar to that used in conventional 2D
cine PC-CMR. However, a few important differences
exist. As mentioned above and illustrated in Fig. 4, the
volumetric coverage of 4D Flow CMR offers retro-
spective positioning of planes for flow volume mea-
surements at any location within the acquired data
volume [37, 47, 49, 162–164]. The use of a 3D or 4D
PC-MR angiogram derived from the 4D Flow CMR
data is recommended for anatomical orientation and
identification of cross-sectional analysis planes for flow
quantification. This may be combined with streamlines
or pathlines visualizations for further guidance of plane
positioning. Segmentation of the lumen can be done with
similar approaches as in 2D cine PC-CMR, but due to
smaller inflow effects, the contrast between blood and
surrounding tissue is inferior in 4D Flow CMR. Another
option is to perform 3D or 4D segmentation during data
processing and use this segmentation as geometrical
boundaries in the flow volume calculation. This approach
can be advantageous for quantification of peak velocity in
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an entire vessel segment rather than relying on 2D analysis
planes which do not coincide with the location of the max-
imum systolic velocity. Studies with 2D PC-CMR have
shown that at least 5–6 voxels across the vessel lumen are
needed for accurate flow volume quantification [165].
Quality control
Quality control is important for every clinical and re-
search study. The versatility of 4D Flow CMR allows
several approaches to be used, that can be included in
imaging and post-processing without excessive add-
itional effort.
Screening of 4D Flow CMR source images can reveal
phase wraps, background phase offsets (by using narrow
color-window), fold-over, and other image artifacts. Further,
with its volumetric coverage, 4D Flow CMR offers several
opportunities for control of the internal data consistency.
For flow volume quantification, the conservation-of-mass
Fig. 2 Examples of 4D Flow CMR visualization techniques. All examples are based on data acquired in the aorta of a healthy volunteer. In these
examples, flow visualization is overlaid onto a segmentation of the aorta. a An oblique slice that transects the aorta has been color-coded by flow
speed and combined with a graph of velocity vectors which here displays the speed and direction of blood velocity in black arrows at a coarser
grid than the acquired voxels. This type of visualization provides a quick overview of velocity fields. b A maximum intensity projection (MIP) image
of flow speed permits identification of areas of elevated velocity and the point of peak velocity while displaying the peak velocities of the whole
volume projected onto this single slice image. c Streamlines are instantaneously tangent to the velocity vector field and are useful to visualize 3D
velocity fields at discrete time points. Here, the peak systolic velocity field is shown. d Pathlines are the trajectories that massless fluid particles
would follow through the dynamic velocity field. Pathlines are suitable for studies of the path of pulsatile blood flow over time. This example
shows pathlines emitted from a plane in the ascending aorta at the onset of systole and traced to early systole (left), peak systole (middle) and
late systole (right). All figures have been color-coded based on flow speed using the same color-window settings according to the scale shown in
(b) and (d). In a, c and d, the visualizations have been combined with a PC-MRA isosurface which has been derived from the 4D Flow CMR data
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principle can be employed to assess pulmonary vs. systemic
flow volume ratios and flow volume in vs. out of the left
ventricle [32, 38, 41–49]. The conservation-of-mass prin-
ciple can also be used for quality control of pathlines
analysis as the number of pathlines that enter and leave a
specified region of interest should be the same (e.g. cardiac
ventricles) [57]. Another complementary approach is to
screen data for streamlines or pathlines that abruptly
change direction or slowly drift out of the lumen, which
can be indicative of phase wraps or uncompensated back-
ground phase offsets, respectively. Similarly, the presence
of uncompensated background phase offsets can be sus-
pected if pathlines emitted from the chest or back move in
a non-random fashion.
The following approaches are recommended for gen-
eral data quality control:
1) Visual inspection of source images
2) Quantitative quality control that targets the
parameter of interest. For example, the
conservation-of-mass principle is an excellent option
when assessing the quality of flow volume
quantification. We emphasize that requirements on
the data depend on the analysis approach; sufficient
data quality for accurate estimation of parameter A
(e.g. peak velocity) does not necessarily imply
accurate estimation of parameter B (e.g. flow
volume). When the quantitative quality control
method matches the analysis parameter of interest,
this may be used as the first-in-line quality control
step.
3) When the quantitative quality control signals poor
data quality, we recommend performing additional
visual inspection of the source images, as well as
inspection of pathlines emitted from static tissue
such as the chest or back.
Controversies and recommendations for future work
The imaging sequences as well as data processing and
analysis methods described in the recommendations
section above constitute the current state of the tech-
nique as it is available at a large number of institutions.
However, the field of 4D Flow CMR is rapidly evolving
with improvements in imaging acquisition methods as
LA 
LV 
AAo
B Instantaneous streamlines at E-wave D Instantaneous streamlines at peak systole C Instantaneous streamlines at A-wave 
A Pathlines emitted from the mitral valve at approx. time of peak A-wave (left panel) and traced to early systole (right panel)  
TECG = 0.66 sec TECG = 0.70 sec TECG = 0.77 sec TECG = 0.80 sec 
Fig. 3 Examples of 4D Flow CMR visualization techniques, demonstrated on intracardiac flow data acquired in a healthy volunteer. In these examples,
flow visualization is overlaid onto a 2D bSSFP acquisition in a three-chamber view. a Pathlines are the trajectories that massless fluid particles would
follow through the dynamic velocity field and are suitable for studies of the path of pulsatile blood flow over time. Here, the transit of blood through
the left ventricle (LV) is shown by pathlines emitted from the mitral valve at the time point of peak A-wave and traced to the time point of early systole
systole. The timing of the ECG (TECG) is included for reference. b-d Streamlines are instantaneously tangent to the velocity vector field and are useful to
visualize 3D velocity fields at discrete time points. Here, streamlines generated in a long-axis plane show parts of the intracardiac velocity field at the
time points of b peak early filling (E-wave), c peak late filling (A-wave), and d peak systole
Dyverfeldt et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:72 Page 10 of 19
well as data processing and analysis techniques. These
development efforts increase the diversity of 4D Flow
CMR. We encourage this trend, but we also see a need
for improved conformity across sites and companies that
develop and use 4D Flow CMR methods. There are also
several limitations of current and emerging methods,
some of which are not fully understood, and it is import-
ant to acknowledge the limitations and develop our
understanding of them, so that improvements can be
made where possible. This section outlines some of the
more advanced techniques and areas for development in
improving data quality and simplifying wide-scale clin-
ical applicability.
Advanced analysis parameters
Beyond the basic flow parameters discussed in the rec-
ommendation section above, a variety of more advanced
analysis parameters are currently used in research set-
tings, including wall shear stress, pressure difference
mapping, kinetic energy, turbulent kinetic energy, energy
dissipation, differential flow analysis, flow angles, flow
displacement, and pulse wave velocity [40, 57, 59, 60,
103, 122, 123, 125–139, 166–168]. The quantitative in-
formation that these parameters provide can distinguish
normal from abnormal blood flow, as well as differen-
tiating types of abnormal hemodynamics. However, the
application of these parameters can be complex. The
effects of underlying assumptions, the impact of the
quality of 4D Flow CMR data on the parameter, and the
physiological meaning of the parameter as estimated
with 4D Flow CMR should be taken into consideration.
While a complete list of analysis parameters is beyond
the scope of this consensus document, Table 3 contains
some of the most common parameters and describes
what they are, potential applications, the controversies
and unmet needs.
Understanding the limits of the technique
Further work is needed to understand the accuracy and
precision of existing and new 4D Flow CMR methods,
Fig. 4 Illustration of retrospective flow quantification. For retrospective quantification of flow parameters based on 2D analysis, planes can be
positioned at any anatomic location. In this example, an isosurface of 3D PC-MRA data derived from the 4D Flow CMR data (gray shaded) has
been used to guide positioning analysis planes throughout the thoracic aorta. For each analysis plane, the vessel contours are segmented for all
cardiac time frames to calculate flow volume, peak velocity and retrograde fraction
Dyverfeldt et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:72 Page 11 of 19
including sequences, reconstruction methods and analysis
parameters. The assessment of spatiotemporal fidelity and
noise propagation of image acquisition, reconstruction
and analysis methods is of key importance. Besides
localization in space and time, any bias or noise-related
uncertainty requires careful consideration, as it not only
depends on the CMR experiment but also on MR system
settings and tuning as shown in a recent 2D PC-CMR
study [155].
Spatial and temporal resolution
The acquisition of 4D Flow CMR data is, in a certain
sense, complete. All dimensions and directions of the
cyclically changing flow field are covered, albeit with
spatial and temporal resolution that does not resolve all
features of the flow. If partial k-space acquisitions are
used, the method used for reconstruction, e.g. zero-
filling or Margosian/homodyne reconstruction, should
be reported [169]. The method needs to be chosen with
respect to its impact on the phase of the MR signal.
While spatial resolution is typically quoted as the ratio
of field-of-view to acquisition matrix, it needs to be em-
phasized that the effective spatial resolution can be less.
Likewise, the ability to resolve temporal features of flow
may not be appropriately captured by quoting the num-
ber of acquired heart phases and any methods for tem-
poral interpolation or view sharing should be reported.
Utilizing the concept of spatiotemporal point-spread
function (PSFxt) or transfer function is recommended
for detailed investigations of a method’s ability to portray
information [170–173]. Choices of spatial and temporal
resolution need to be made according to the degree of
spatial localization and temporal bandwidth required to
sufficiently describe, depict, and measure the flow fea-
ture of interest. We emphasize that resolution is driven
by application, and recommendations for measuring
parameters such as flow volume may not be sufficient
for quantities such as wall shear stress or pulse wave vel-
ocity. Careful choices and investigations are required if
quantities are derived from the measured velocity vector
fields including spatial and temporal velocity derivatives
as required for assessing wall shear stresses, relative
pressure fields or pulse wave velocities, for example.
Many parameters are directly affected by the choice of
temporal and spatial resolution and therefore the impact
of spatial and temporal resolution on the accuracy and
precision of a given parameter should be considered. It
is recommended to assess if a different resolution would
produce a different result. As a way of avoiding
direction-dependent estimates, the acquisition of iso-
tropic voxels is recommended. If this is not possible, the
effect of voxel anisotropy should be investigated.
Mean flow and small-scale variation in velocity
The time-resolved velocity fields measured with 4D Flow
CMR are mean velocity fields and should be viewed as
such. Spatial averaging occurs over the spatial extent of
the voxel, and each measured cardiac phase (time frame)
represents flow fields effectively averaged (phase-aver-
aged) over multiple cardiac cycles extending over several
Table 3 Commonly used advanced analysis parameters
Target parameter Description Potential applications Requirements and uncertainties
Wall Shear Stress (WSS)
[93, 125, 126, 193]
Viscous shear forces of flowing
blood acting tangentially to
the vessel wall
Indicator for impact of flow alterations
on endothelial cell and extracellular
matrix function and risk for vessel wall
remodelling
Dependent on spatial resolution. Relationship
to actual WSS values are unclear [127, 173].
Limited longitudinal data that demonstrates
its predictive value for risk stratification.
Pulse Wave Velocity (PWV)
[132, 133, 168]
Propagation speed of systolic
pressure pulse in the arterial
system
Marker of arterial stiffness and
predictive of cardiovascular disease.
Requires high temporal resolution. Sensitive
to artifacts.
Turbulent Kinetic Energy
(TKE) [134, 136, 137]
Energy content of turbulent flow
and direction-independent
measure of intensity of turbulent
velocity fluctuations
Estimate of turbulence-related loss of
energy or pressure. Indicator of impact
of turbulent flow on blood constituents
or vessel wall.
The effect of intravoxel mean velocity
variations affects the estimation of low TKE
values. Is based on information from signal
magnitude data from each individual flow-
encoding segment, which are usually not
obtained in standard reconstructions.
Relative Pressure Fields
[128, 129, 131]
Relative blood pressure field Noninvasive estimation of pressure
differences
Pressure field calculations based on MR
velocity data do not take turbulence effects
into account and do therefore not reflect
turbulence-related pressure losses that occur in
stenotic flows. Computation of pressure fields
is associated with several pitfalls and a best
strategy has not been established.
Volume and Kinetic Energy
of Ventricular Flow
Components or
Compartments [56, 57, 59]
Separation of blood that transits
heart chambers according to
compartmental origin and fate
Indicator of ventricular dysfunction.
Risk stratification and optimization
and individualization of treatment
heart failure
Pathlines used to map the transit of blood
through the chambers accumulate errors that
are inversely related to the quality of velocity
data. Mixing effects are unknown.
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minutes. The spatiotemporal resolution and effective
averaging over multiple cardiac cycles limits the size of
the flow features that can be characterized with velocity
mapping techniques. However, the measured mean vel-
ocity field is accurate and corresponds very well to the
actual mean velocity field [174–176]. In disturbed and
turbulent flows, a fluctuating velocity field is superim-
posed on the mean velocity field. These small-scale vel-
ocity fluctuations are thus not resolved by 2D or 4D
Flow CMR velocity mapping. In fact, resolving all scales
of velocity is not a realistic goal for 4D Flow CMR vel-
ocity mapping, as this would require <0.1 mm spatial
resolution and <1 ms real-time temporal resolution.
However, this aspect of flow can be addressed by a com-
plementary 4D Flow CMR technique referred to as
intravoxel velocity standard deviation (IVSD) mapping,
or turbulence mapping. This technique, which can be
viewed as a flow-analogue to diffusion-weighted im-
aging, is based on an MR signal model that describes the
relationship between the amplitude (not phase) of the
PC-CMR signal and the range of velocities that are
present in a voxel. The IVSD mapping technique per-
mits the estimation of the intensity of turbulent velocity
fluctuations and turbulent kinetic energy in stenotic
flows [135, 174, 176, 177]. Its application in flows with
only minor fluctuations may be hampered by the fact
that laminar flow effects such as shear also give rise to
intravoxel velocity variations that contribute to the mea-
sured IVSD. However, this effect appears to be small
compared to intravoxel velocity variations caused by
unstable fluctuations [60, 135].
Noise propagation and confidence
Noise remains a limitation of the technique. An important
parameter with respect to noise is the venc parameter that
determines the velocity sensitivity of a 4D Flow CMR ac-
quisition. The VNR is inversely proportional to the venc.
Consequently, for a given venc, the estimation of low blood
flow velocities < < venc is less reliable compared to flow
velocities closer to venc. This can particularly be a limiting
factor for multi-purpose flow analysis (e.g. quantification of
both high flow velocities in a stenotic aorta and low flow
velocities in a cardiac shunt in the same patient). New
sequences are under development that permit the use of
two or more venc’s [137, 147, 178]. In addition, other strat-
egies can be employed to maximize SNR and VNR. This
includes optimizing the experimental setup, including main
magnetic field strength and receive-coil instrumentation,
as well as protocol modifications.
Further work is required to understand the impact of
noise, and we recommend the method of pseudo rep-
licas [179, 180] to study and assess SNR and VNR
dependencies and noise propagation. Accordingly, differ-
ent noise realizations of same statistics are added to the
original MR raw data and image reconstruction or par-
ameter calculation is repeated to provide confidence
intervals of velocity values. In a similar fashion, post-
processing strategies including the impact of region-of-
interest analysis can be tested and referenced.
Systematic errors
Systematic errors causing unwanted bias of the measured
velocity field are typically related to gradient induced
eddy-currents, concomitant gradient fields and gradient
non-linearity [148–151, 154]. While the latter two sources
of error are corrected/calibrated with sufficient accuracy
by clinical MR systems, eddy-currents depend on a range
of parameters including the pre-emphasis settings of an
individual MR system, gradient performance, orientation
of the image volume and temperature of the gradient
mount. Accordingly, prediction of the bias is often impos-
sible and correction methods need to be applied retro-
spectively during image post-processing.
It is recommended to carefully study potential bias in
a static gel phantom under identical experimental condi-
tions, including navigators. This includes analysis of the
spatial order of eddy-current induced background phase
errors for each acquired heart phase [181]. If phantom
calibration is applied routinely to subtract potential
background phase offsets, fitted functions should be
used to avoid compromising SNR/VNR of the original
data upon subtraction. If background phase errors are
corrected for by fitting polynomials through the phase of
tissue known to be static, the fit error needs to be
weighted against the degrees of freedom of the fit func-
tion to avoid over- or underfitting. Assessment of heart-
phase dependent differences is recommended.
Validation
In-vivo comparison against current gold-standard methods
is lacking for many areas of 4D Flow CMR, often due to
the lack of such a gold standard for in-vivo assessment. The
entire chain of data acquisition, reconstruction and image
processing should, if possible, be evaluated for accuracy
and precision. It is helpful to compare with existing tech-
niques, where they exist. However, 4D Flow CMR may pro-
vide more accurate quantification and so potentially
become the new gold-standard, or it may be the only tech-
nique capable of assessing certain parameters. For areas
where an in-vivo gold-standard is lacking, controlled steady
and pulsatile flow phantom experiments with accurate
reference quantification can be used to assess accuracy. In
view of the range of commercial and custom-built phan-
toms available, it should be feasible to validate applications
by simulating flow rates and pulsatility (e.g. Reynolds and
Womersley number), cycle-to-cycle variation and presence
of sufficient static tissue for background correction. Refer-
ence methods (Particle Tracking or Image Velocimetry,
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Laser Doppler Anemometry) can also be used to establish
baseline data in-vitro. Numerical phantoms providing
idealized model data are important for the study of certain
aspects of data reconstruction and processing in flow fields
that are fully known. Evaluation of precision should
include testing sensitivity especially to spatiotemporal
resolution and SNR, which can be done in-vivo, in-vitro,
or using simulations.
Status of implementation and standardization
Sequence
In addition to the sequence settings described in
Table 2, several options exist for non-Cartesian 4D
Flow CMR [182–186]. Different acquisition strategies
(Cartesian, spiral, radial, EPI, bSSFP, etc.) have differ-
ent strengths and weaknesses and thus the optimal
acquisition strategy depends on the targeted applica-
tion and analysis parameter. Moreover, in addition to
standard parallel imaging, more advanced acceleration
techniques have shown promising results and there
exists many options for reduction of 4D Flow CMR
scan times [39, 49, 187–192]. Reduced scan times are
particularly relevant to applications in smaller vessels
where higher resolution is needed.
At the time of writing, none of the major MR systems
manufacturers (GE, Philips, Siemens) routinely provide
4D Flow CMR sequences or packages to researchers or
clinical users. On Philips scanners, however, the neces-
sary sequence exists and users can set up a 4D Flow
CMR protocol (‘exam card’), similar to the consensus
protocol, on a standard commercial system without any
software modifications. Siemens offer a ‘work-in-pro-
gress’ package to selected users. Due to the lack of
widely available commercial 4D Flow CMR sequences, a
large number of studies and applications are still based
on 4D Flow pulse sequences that individual research
groups have developed in-house and shared with collab-
orators worldwide. 4D Flow CMR pulse sequences imple-
mented by research groups exist in a variety of flavors
(different k-space trajectories, acceleration methods, etc.)
and for all major MR platforms (GE, Philips, Siemens).
The lack of standardization across MR platforms (even for
the same vendor) and data output formats, as well as the
absence of commercial 4D Flow CMR sequences and
protocols are limiting factors that hinder introduction of
the technique to the clinical environment.
Software for pre-processing, visualization and flow
quantification
Pre-processing, visualization and flow quantification is be-
ing performed using in-house developed tools, early-stage
commercial packages, or manufacturer prototypes. The
field would benefit from greater standardization in data
analysis methods, workflows, and data output formats,
which in turn affect the use of analysis tools. Wide clinical
utility would benefit from the availability of user-friendly
tools that are integrated in MR scanner consoles and
workstations, as well as PACS systems. This would ideally
include the following capabilities: 1) retrospective flow
quantification on the scanner console and/or workstations
and/or PACS system, 2) analysis and representation of
clinically relevant parameters such as flow waveforms and
cardiac output in DICOM format 3) 4D Flow visualiza-
tions on MR scanner console and/or workstations and/or
PACS systems, and 4) animations in DICOM format to
store and display in PACS. We encourage vendors and
third-party developers to consider implementing these key
features as a basis for more routine clinical use of 4D Flow
CMR.
Conclusion
Relatively easy scan prescription and retrospective
placement of analysis planes makes 4D Flow CMR a
potentially advantageous tool in the clinical setting,
particularly if several regions and directions of flow
merit investigation. Conventional flow parameters can
be obtained at any location in the data volume where
the employed parameter settings provide sufficient
accuracy. At the same time, 4D Flow CMR visualiza-
tions offer more versatile and comprehensive depictions
of flow fields than any other in-vivo imaging technique.
Further, advanced 4D Flow CMR analysis parameters
are currently used in the research setting but require
testing for clinical utility. Widespread clinical usage would
be facilitated by further integration into the standard MR
environment. Multicenter studies are necessary to estab-
lish the repeatability of various aspects of the technique
across centers.
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